This review underscores the role of extracellular histones as pivotal mediators and biomarkers in sepsis, advocating their use for diagnosis, prognosis, and treatment monitoring. The integration of quantitative proteomics for circulating histone detection holds promise for improving patient stratification and guiding therapeutic decisions — a step forward toward personalized medicine in critical care.